Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 4;4(9):512-515.
doi: 10.1016/j.jaccas.2021.12.008.

Concomitant Redo Transcatheter Aortic Valve Replacement and Valve-in-Mitral Annular Calcification

Affiliations
Case Reports

Concomitant Redo Transcatheter Aortic Valve Replacement and Valve-in-Mitral Annular Calcification

Vinayak Nagaraja et al. JACC Case Rep. .

Abstract

Contemporary challenges in structural heart intervention include redo transcatheter aortic valve replacement and transcatheter mitral valve replacement in severe mitral annular calcification. We report a case of concomitant redo transcatheter aortic valve replacement and transcatheter mitral valve replacement in mitral annular calcification in a patient with radiation heart disease. (Level of Difficulty: Advanced.).

Keywords: AR, aortic regurgitation; ASD, atrial septal defect; LVOT, left ventricular outflow tract; MAC, mitral annular calcification; MR, mitral regurgitation; TAVR, transcatheter aortic valve replacement; TMVR, transcatheter mitral valve replacement; chemoradiotherapy; mitral valve; mitral valve stenosis; transcatheter aortic valve replacement; transcatheter mitral valve replacement.

PubMed Disclaimer

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Relationship Between the Coronary Ostia and the Patient’s Original Aortic Replacement Valve Coronary angiogram of the left main coronary artery showing minimal coronary disease and demonstrating the relationship between the coronary ostia and the patient’s original aortic replacement valve. ^23-mm Sapien XT. Left main coronary artery. ∗∗Left anterior descending artery.
Figure 2
Figure 2
Paravalvular Leak Closure A 12-mm self-expandable nitinol mesh occlusion device (∗∗) was deployed across the paravalvular leak. ∗Redo TAVR with 23-mm Sapien S3.
Figure 3
Figure 3
Iatrogenic Atrial Septal Defect Closure An 8-mm atrial septal defect occluder (∗∗) was deployed across the iatrogenic atrial septal defect. ∗12-mm self-expandable nitinol mesh occlusion device. ^Redo TAVR. ^^TMVR ViMAC.

References

    1. Siontis G.C.M., Overtchouk P., Cahill T.J., et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019;40:3143–3153. - PubMed
    1. Landes U., Webb J.G., De Backer O., et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol. 2020;75:1882–1893. - PubMed
    1. Guerrero M., Urena M., Himbert D., et al. 1-Year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71:1841–1853. - PubMed
    1. Yoon S.H., Whisenant B.K., Bleiziffer S., et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441–451. - PubMed

Publication types